Genomic DNA (5-40 ng) or cell-free DNA (from ~1 mL of whole blood) was digested using multiple restriction enzymes [Set1: AlwNI and Alw26I; Set2: EarI and NcoI; SetKC: EarI and 
The linear amplification products were purified once with a 1.2x volume of AMPureXP, and the purified beads were dissolved in 20 µL of PCR amplification solution: 1x High Fidelity PCR Buffer (Life Technologies), 0.2 mM dNTPs, 2 mM MgSO4, 0.5 µM each of the PGM/Proton primers (Supplementary Table S2 ), and 0.4 units of Platinum Taq High Fidelity (Life Technologies).
Thermal cycling after the removal of the AMPureXP beads was performed as follows: 2 min at 95 °C for denaturation and 30 cycles of 15 sec at 95 °C and 1 min at 60 °C (for TP53) or 63 °C (for KRAS/CTNNB1). To compare error rates between the DNA polymerases that were used for the final amplification step, purified linear amplification products were also amplified in 20 µL of solution: 1x Q5 Reaction Buffer, 0.2 mM dNTPs, 0.5 µM PGM/Proton primers, and 0.4 units of Q5 Hot Start High-Fidelity DNA Polymerase. Thermal cycling was performed for 30 sec at 98 °C for denaturation and 30 cycles of 10 sec at 98 °C, 10 sec at 65 °C, and 15 sec at 72 °C. The final amplification products that were obtained using Platinum Taq High Fidelity exhibited clearer bands after agarose gel electrophoresis than those obtained using Q5 DNA polymerase; thus, we primarily used Platinum Taq High Fidelity for the final amplification. For the preparation of libraries for analysis by the Illumina system, the final PCR amplification step was performed 1 using indexed oligonucleotides for the discrimination of individual samples (Supplementary   Table S3 ) and Platinum Taq High Fidelity. The amplification products were purified twice with a 1.0x volume of AMPureXP and eluted in 20 µL of nuclease-free water (Ambion, TX, USA). When the final amplification products were prepared using Q5 DNA polymerase, the suggested method for the Illumina system, or the KRAS/CTNNB1 assay, the products were purified using agarose gel electrophoresis with a MinElute Gel Extraction Kit (Qiagen).
Library construction for experiments with double strand labeling
The digestion of genomic DNA by restriction enzymes and adaptor-ligation were performed as described above. The purified ligation products were mixed in 20 µL of Platinum Taq High Fidelity PCR solution containing 0.5 µM T_PCR_A and a 0.5 µM region-specific primer mixture (Supplementary Table S2 ). The PCR mixture was incubated for 20 or 30 min at 72 °C for replacement synthesis by Pyrococcus GB-D polymerase using the Platinum Taq DNA Polymerase High Fidelity kit and amplified as follows: 30 cycles of 15 sec at 95 °C and 1 min at 60 °C. The validity of the double strand labeling was confirmed using a model experiment with a mixture of heteroduplex DNA fragments. PCR fragments from normal individuals (Megapool) and from a cell line with a mutation in TP53 (MIA PaCa-2) were mixed at a ratio of 100 to 1, denatured, and renatured. Library construction was performed as described above, with or without replacement synthesis. The use of replacement synthesis resulted in an approximately 10-fold reduction in the rate of mutation detection (Supplementary Figure S1 and Table S4 ).
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Supplementary Figure S1 Supplementary Figure S1 . Construction of heteroduplex fragments with base substitutions.
As models for DNA lesions, we prepared heteroduplex DNA fragments by mixing R280W mutant (from MIAPaCa-2) and wild type (from Megapool) PCR fragments at a ratio of 100 to 1. These artificial heteroduplex fragments were digested by restriction enzymes and attached to adaptors.
We then generated fully double-stranded fragments using the strand displacement capability of Pyrococcus GB-D polymerase using a Platinum Taq DNA Polymerase High Fidelity kit (Life STechnologies) and amplified the sequences by PCR without linear amplification ( Figure 1A) .
The libraries were sequenced and analyzed using the barcode-tags.
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Supplementary Figure R248W homologous mutation and from Megapool (wild type) were mixed at ratios, 1:0, 3:1, 1:1, 1:3, and they were used for preparation of sequencing libraries as described in method section.
Fractions of variants (R248W) were analyzed with the use of barcodes (Tag(+)) or without that (Tag(-)).
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Supplementary Figure S4 Supplementary Figure S4 . Estimated number of target molecules after removing 1-or 2-read tags. The data used in Figure 2E were reanalyzed.
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Supplementary Figure were performed using reads that were randomly extracted from the entire set of reads ("5ng": 343,932; "10ng": 404,900; "20ng": 548,809; "40ng": 594,719 reads) . Figure S1) . After constructed consensus of multiple reads using barcode tags, bases of R248W mutation position of TP53 were counted. Valiant frequency by both strands sequencing was 0.1%, suggesting that 90% of base changes in one strand were discriminated.
"double strands" were labeled with the same barcode by replacement synthesis of the complementary strand, and sequenced ( Figure 1A ). For "one strand"
sequencing, replacement synthesis of the complementary strand was not done.
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